Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia
Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
A six-month study to determine the safety and efficacy with an additional open-label
extension to determine the long-term safety of eszopiclone in the treatment of adult subjects
with primary insomnia.